Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...

Enanta Pharmaceuticals remains a Buy as zelicapavir shows promise in RSV trials; strong financials support growth. Read why ...

Objective To understand how health insurance coverage and employment changed among working age adults with low incomes in Georgia, the first state to implement Medicaid expansion with work ...

CRYPTICS study met the primary efficacy endpoint measure, 24-hour chest tube drainage (Difference in LS Means was 142.0 mL; 95.576% confidence ...

The trial’s findings will dampen enthusiasm for the drug in stroke recovery, though research questions remain, one expert ...

Kingston's new Renegade G5 aced our performance testing, falling a hair shy of the overall top spot. But it took the top spot ...

Surgical success of trabeculectomy in the first-operated eye increased the odds of success in the second-operated eye for ...

The incidence of syphilis is rising across US populations, with congenital syphilis and drug shortages posing major public ...

Fragranced consumer products emit volatile organic compounds that form nanoparticles, contributing to indoor air pollution ...

Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies geographically. Large trials are needed to assess safety and effectiveness.